Somerset Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,965
Closed -$240K 74
2017
Q3
$240K Hold
2,965
0.22% 65
2017
Q2
$210K Hold
2,965
0.19% 70
2017
Q1
$201K Sell
2,965
-200
-6% -$14.1K 0.19% 69
2016
Q4
$227K Sell
3,165
-455
-13% -$33.8K 0.22% 64
2016
Q3
$286K Hold
3,620
0.29% 62
2016
Q2
$302K Sell
3,620
-100
-3% -$8.88K 0.32% 58
2016
Q1
$342K Sell
3,720
-1,200
-24% -$108K 0.37% 53
2015
Q4
$498K Sell
4,920
-1,245
-20% -$130K 0.53% 46
2015
Q3
$605K Buy
6,165
+40
+0.7% +$4.44K 0.66% 40
2015
Q2
$717K Sell
6,125
-500
-8% -$54.6K 0.68% 39
2015
Q1
$650K Sell
6,625
-400
-6% -$40.6K 0.58% 43
2014
Q4
$662K Buy
7,025
+275
+4% +$28.4K 0.59% 44
2014
Q3
$719K Hold
6,750
0.66% 42
2014
Q2
$560K Buy
6,750
+30
+0.4% +$2.33K 0.51% 46
2014
Q1
$476K Hold
6,720
0.45% 52
2013
Q4
$505K Buy
6,720
+3,055
+83% +$213K 0.4% 51
2013
Q3
$230K Buy
+3,665
New +$219K 0.17% 71

Other funds holding GILD

Somerset Group's GILD Position: Q4 2017 in Review

Somerset Group sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,965 shares — an estimated $240K sold.

Somerset Group first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $719K in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Somerset Group reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Somerset Group sold 2,965 Gilead Sciences shares in Q4 2017, an estimated $240K.
  • Somerset Group first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
  • Somerset Group's Gilead Sciences position peaked at $719K in Q3 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Somerset Group's 13F filing for Q4 2017, filed 12 Feb 2018.